Coronavirus Report – Part 91: GSK Japan President Paul Lirette Discusses Strategy and Moves in Pandemic Times
A global leader in its field, GlaxoSmithKline PLC (GSK) has been developing vaccines against a myriad of infectious diseases for……
Please subscribe to read the full story.
Author
